JP2012528794A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012528794A5 JP2012528794A5 JP2012513332A JP2012513332A JP2012528794A5 JP 2012528794 A5 JP2012528794 A5 JP 2012528794A5 JP 2012513332 A JP2012513332 A JP 2012513332A JP 2012513332 A JP2012513332 A JP 2012513332A JP 2012528794 A5 JP2012528794 A5 JP 2012528794A5
- Authority
- JP
- Japan
- Prior art keywords
- vaccine composition
- subject
- composition
- dengue virus
- dengue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 23
- 229960005486 vaccine Drugs 0.000 claims 18
- 241000725619 Dengue virus Species 0.000 claims 10
- 239000003446 ligand Substances 0.000 claims 6
- 238000000034 method Methods 0.000 claims 6
- 238000002347 injection Methods 0.000 claims 5
- 239000007924 injection Substances 0.000 claims 5
- 208000001490 Dengue Diseases 0.000 claims 4
- 206010012310 Dengue fever Diseases 0.000 claims 4
- 208000025729 dengue disease Diseases 0.000 claims 4
- 230000002163 immunogen Effects 0.000 claims 4
- 239000002671 adjuvant Substances 0.000 claims 2
- 239000000147 enterotoxin Substances 0.000 claims 2
- 231100000655 enterotoxin Toxicity 0.000 claims 2
- 230000001939 inductive effect Effects 0.000 claims 2
- 229940046168 CpG oligodeoxynucleotide Drugs 0.000 claims 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims 1
- 108091036414 Polyinosinic:polycytidylic acid Proteins 0.000 claims 1
- 230000002238 attenuated effect Effects 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- DOUYETYNHWVLEO-UHFFFAOYSA-N imiquimod Chemical compound C1=CC=CC2=C3N(CC(C)C)C=NC3=C(N)N=C21 DOUYETYNHWVLEO-UHFFFAOYSA-N 0.000 claims 1
- 229960002751 imiquimod Drugs 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 231100000252 nontoxic Toxicity 0.000 claims 1
- 230000003000 nontoxic effect Effects 0.000 claims 1
- 229910052698 phosphorus Inorganic materials 0.000 claims 1
- 239000011574 phosphorus Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18302009P | 2009-06-01 | 2009-06-01 | |
| US61/183,020 | 2009-06-01 | ||
| PCT/US2010/036726 WO2010141386A1 (en) | 2009-06-01 | 2010-05-28 | Compositions and methods for administration of vaccines against dengue virus |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015230723A Division JP2016033151A (ja) | 2009-06-01 | 2015-11-26 | デングウイルスに対する免疫原性組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012528794A JP2012528794A (ja) | 2012-11-15 |
| JP2012528794A5 true JP2012528794A5 (cg-RX-API-DMAC10.html) | 2013-07-18 |
| JP5848243B2 JP5848243B2 (ja) | 2016-01-27 |
Family
ID=43220488
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012513332A Expired - Fee Related JP5848243B2 (ja) | 2009-06-01 | 2010-05-28 | デングウイルスに対する免疫原性組成物 |
| JP2015230723A Pending JP2016033151A (ja) | 2009-06-01 | 2015-11-26 | デングウイルスに対する免疫原性組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015230723A Pending JP2016033151A (ja) | 2009-06-01 | 2015-11-26 | デングウイルスに対する免疫原性組成物 |
Country Status (17)
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013188315A1 (en) * | 2012-06-10 | 2013-12-19 | Inviragen, Inc. | Compositions and methods for administration of vaccines against dengue virus |
| US8968996B2 (en) | 2009-06-01 | 2015-03-03 | Takeda Vaccines, Inc. | Compositions and methods for rapid immunization against dengue virus |
| CN102449172A (zh) | 2009-06-01 | 2012-05-09 | 伊维拉根公司 | 施用针对登革病毒的疫苗的组合物和方法 |
| EP2931310A4 (en) * | 2012-12-14 | 2016-05-25 | Takeda Vaccines Inc | COMPOSITIONS, METHODS OF ADMINISTRATION AND USES OF TRIVALENT FORMULATIONS AGAINST DENGUE VIRUS |
| CA3177574C (en) | 2013-03-15 | 2026-03-31 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Compositions and methods for dengue virus chimeric constructs in vaccines |
| JP2019511533A (ja) | 2016-04-13 | 2019-04-25 | タケダ ワクチン, インコーポレイテッドTakeda Vaccines, Inc. | 小児及び若年成人のデングウイルスに対するワクチンの組成物及び方法 |
| CA3086456A1 (en) | 2017-12-21 | 2019-06-27 | Kirin Holdings Kabushiki Kaisha | Cross-immunizing antigen vaccine and method for preparation thereof |
| US11426461B2 (en) | 2018-09-05 | 2022-08-30 | Takeda Vaccines, Inc. | Methods for preventing dengue and hepatitis A |
| US11590221B2 (en) | 2018-09-05 | 2023-02-28 | Takeda Vaccines, Inc. | Dengue vaccine unit dose and administration thereof |
| US11464815B2 (en) | 2018-09-05 | 2022-10-11 | Takeda Vaccines, Inc. | Dengue vaccine unit dose and administration thereof |
| GB202011055D0 (en) * | 2020-07-17 | 2020-09-02 | Ipsen Bioinnovation Ltd | Treatment of post-operative pain |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0872553B1 (en) * | 1991-09-19 | 2000-11-15 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the Secretary of the Department of HEALTH AND HUMAN SERVICES | Chimeric and/or growth-restricted flaviviruses |
| FR2741077B1 (fr) * | 1995-11-14 | 1998-01-23 | Pasteur Institut | Vaccin polyvalent anti-dengue |
| AU779280B2 (en) * | 1999-03-26 | 2005-01-13 | Walter Reed Army Institute Of Research | Multivalent dengue virus vaccine |
| DK2278012T3 (en) | 2000-02-16 | 2015-12-07 | Us Government | Immunogenic dengue 2 virus chimeras |
| EP1159969A1 (fr) * | 2000-05-30 | 2001-12-05 | Aventis Pasteur | Vaccine composition |
| CA2755964C (en) | 2001-05-22 | 2017-06-27 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses |
| GB0123580D0 (en) * | 2001-10-01 | 2001-11-21 | Glaxosmithkline Biolog Sa | Vaccine |
| US20040120964A1 (en) * | 2001-10-29 | 2004-06-24 | Mikszta John A. | Needleless vaccination using chimeric yellow fever vaccine-vectored vaccines against heterologous flaviviruses |
| AU2003239932A1 (en) * | 2002-05-31 | 2003-12-19 | Acambis, Inc. | Tetravalent dengue vaccines |
| SG156666A1 (en) * | 2004-10-20 | 2009-11-26 | Acambis Inc | Vaccines against japanese encephalitis virus and west nile virus |
| US8110196B2 (en) | 2005-04-29 | 2012-02-07 | Polytopas LLC | Methods and compositions for polytopic vaccination |
| US7618393B2 (en) * | 2005-05-03 | 2009-11-17 | Pharmajet, Inc. | Needle-less injector and method of fluid delivery |
| DE602006015807D1 (de) * | 2005-06-17 | 2010-09-09 | Ct S For Disease Control & Pre | Abgeschwächter dengue-serotyp-2-stamm |
| WO2007021672A2 (en) * | 2005-08-10 | 2007-02-22 | Acambis Inc. | Vaccination against dengue virus infection |
| ZA200802176B (en) * | 2005-08-10 | 2009-08-26 | Acambis Inc | Vaccination against dengue virus infection |
| DK2054428T3 (da) * | 2006-08-15 | 2013-08-26 | Government Of The U S A As Repr By The Secretary Dept Of Health & Human Services The Nat Inst Of Hea | Udvikling af bestanddele til denque-virus-vaccine |
| FR2906724B1 (fr) * | 2006-10-04 | 2009-03-20 | Sanofi Pasteur Sa | Methode d'immunisation contre les 4 serotypes de la dengue. |
| FR2909286B1 (fr) * | 2006-12-01 | 2012-06-08 | Sanofi Pasteur | Methode d'immunisation contre les 4 serotypes de la dengue |
| WO2008085288A1 (en) * | 2007-01-11 | 2008-07-17 | Sealed Air Corporation (Us) | Method of shaping insulation |
| US20100316670A1 (en) | 2007-06-14 | 2010-12-16 | Blaney Joseph E | Chimeric sle/dengue type 4 antigenic viruses |
| US8968996B2 (en) | 2009-06-01 | 2015-03-03 | Takeda Vaccines, Inc. | Compositions and methods for rapid immunization against dengue virus |
| CN102449172A (zh) | 2009-06-01 | 2012-05-09 | 伊维拉根公司 | 施用针对登革病毒的疫苗的组合物和方法 |
-
2010
- 2010-05-28 CN CN2010800241489A patent/CN102449172A/zh active Pending
- 2010-05-28 MX MX2011012807A patent/MX343172B/es active IP Right Grant
- 2010-05-28 NZ NZ618158A patent/NZ618158A/en not_active IP Right Cessation
- 2010-05-28 JP JP2012513332A patent/JP5848243B2/ja not_active Expired - Fee Related
- 2010-05-28 AU AU2010256845A patent/AU2010256845B2/en not_active Ceased
- 2010-05-28 CN CN201711026301.1A patent/CN107913406A/zh active Pending
- 2010-05-28 CA CA2763944A patent/CA2763944A1/en not_active Abandoned
- 2010-05-28 KR KR1020117031022A patent/KR101876304B1/ko not_active Expired - Fee Related
- 2010-05-28 WO PCT/US2010/036726 patent/WO2010141386A1/en not_active Ceased
- 2010-05-28 NZ NZ597000A patent/NZ597000A/en not_active IP Right Cessation
- 2010-05-28 EP EP10783881.5A patent/EP2438198A4/en not_active Withdrawn
- 2010-05-28 SG SG2011088788A patent/SG176299A1/en unknown
- 2010-05-28 MY MYPI2011005768A patent/MY184428A/en unknown
- 2010-05-28 US US12/790,511 patent/US9211323B2/en not_active Expired - Fee Related
-
2011
- 2011-11-29 CU CU20110219A patent/CU20110219A7/es unknown
- 2011-11-30 IL IL216706A patent/IL216706A0/en not_active IP Right Cessation
- 2011-12-01 CL CL2011003043A patent/CL2011003043A1/es unknown
- 2011-12-12 CO CO11170641A patent/CO6470882A2/es not_active Application Discontinuation
-
2015
- 2015-11-06 US US14/935,281 patent/US10010600B2/en not_active Expired - Fee Related
- 2015-11-26 JP JP2015230723A patent/JP2016033151A/ja active Pending
- 2015-12-17 IL IL243204A patent/IL243204A0/en unknown
-
2016
- 2016-12-05 PH PH12016502431A patent/PH12016502431A1/en unknown
- 2016-12-22 AU AU2016277660A patent/AU2016277660A1/en not_active Abandoned
-
2019
- 2019-01-11 AU AU2019200212A patent/AU2019200212A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ597000A (en) | Compositions and methods for administration of vaccines against dengue virus | |
| JP2012506411A5 (cg-RX-API-DMAC10.html) | ||
| MY169275A (en) | Method of immunization against the four serotypes of dengue | |
| JP2014528901A5 (cg-RX-API-DMAC10.html) | ||
| HRP20200072T1 (hr) | Načini doziranja za spojeve klase ehinokandina | |
| BR112012010443A2 (pt) | formulação de fármacos e vacinas na forma de agulhas injetáveis por via percutãnea | |
| RU2015152860A (ru) | Режим введения и составы для аденовирусов типа в | |
| JP2003513935A5 (cg-RX-API-DMAC10.html) | ||
| JP2016531853A5 (cg-RX-API-DMAC10.html) | ||
| JP2009514840A5 (cg-RX-API-DMAC10.html) | ||
| EA201170569A1 (ru) | Лекарственное средство для повышения дозы противоаллергической вакцины | |
| JP2009518410A5 (cg-RX-API-DMAC10.html) | ||
| JP2017502058A5 (cg-RX-API-DMAC10.html) | ||
| JP2017537106A5 (cg-RX-API-DMAC10.html) | ||
| RU2017126153A (ru) | Фармацевтическая комбинация | |
| Chaudhary et al. | Oral premedication with pregabalin and clonidine for hemodynamic stability during laryngoscopy: A comparative study. | |
| WO2005084387A3 (en) | Methods and compositions for hybrid cell vaccines for the treatment and prevention of cancer | |
| RU2524430C1 (ru) | Вакцина для профилактики сибирской язвы и некробактериоза животных и способ получения ее | |
| CN105030765A (zh) | 一种镇痛药物组合物及其应用 | |
| KR102494067B1 (ko) | 홍역 백신을 포함하는 용해성 미세바늘 패치 | |
| Lim et al. | Safety and reactogenicity of DTPa-HBV-IPV/Hib and DTPa-IPV/Hib vaccines in a post-marketing surveillance setting | |
| RU2017132445A (ru) | Дозы панобиностата для множественной миеломы | |
| RU2018137036A (ru) | Комбинированная вакцина против инфекции вирусами pcv2 и prrs, содержащая альбумин | |
| JP2019509302A5 (cg-RX-API-DMAC10.html) | ||
| BR112017012546B1 (pt) | Composição de vacina antirrábica, kit farmacêutico e uso da composição de vacina antirrábica |